Survival and low-grade glioma: the emergence of genetic information

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

(2015) Yuchen Jiao et al.   Oncotarget

Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk

(2014) Kyle M Walsh et al.   NATURE GENETICS

Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma

(2014) Xiaowei Guan et al.   PLoS One

Analysis of 60 Reported Glioma Risk SNPs Replicates Published GWAS Findings but Fails to Replicate Associations From Published Candidate-Gene Studies

(2013) Kyle M. Walsh et al.   GENETIC EPIDEMIOLOGY

Use of Statins and the Risk of Death in Patients With Prostate Cancer

(2013) Oriana Yu et al.   JOURNAL OF CLINICAL ONCOLOGY

Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology

(2013) T. Rice et al.   NEURO-ONCOLOGY

SSBP2 Variants Are Associated with Survival in Glioblastoma Patients

(2012) Y. Xiao et al.   CLINICAL CANCER RESEARCH

Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas

(2012) Asgeir S. Jakola et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

(2012) Edward G. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY

RareTP53genetic variant associated with glioma risk and outcome

(2012) Kathleen M Egan et al.   JOURNAL OF MEDICAL GENETICS

IDH mutation impairs histone demethylation and results in a block to cell differentiation

(2012) Chao Lu et al.   NATURE

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

(2012) Sevin Turcan et al.   NATURE

A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation

(2012) Robert B Jenkins et al.   NATURE GENETICS

Association of Sequence Variants on Chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) With Glioma Susceptibility in a Chinese Population

(2011) Hongyan Chen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Genome-Wide High-Density SNP Linkage Search for Glioma Susceptibility Loci: Results from the Gliogene Consortium

(2011) S. Shete et al.   CANCER RESEARCH

Molecular Markers in Low-Grade Gliomas: Predictive or Prognostic?

(2011) C. Hartmann et al.   CLINICAL CANCER RESEARCH

Chromosome 7p11.2 (EGFR) variation influences glioma risk

(2011) Marc Sanson et al.   HUMAN MOLECULAR GENETICS

Compromised Health-Related Quality of Life in Patients With Low-Grade Glioma

(2011) Neil K. Aaronson et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer susceptibility variants and the risk of adult glioma in a US case–control study

(2011) Kathleen M. Egan et al.   JOURNAL OF NEURO-ONCOLOGY

DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma

(2011) P. Rajaraman et al.   NEURO-ONCOLOGY

A multigene predictor of outcome in glioblastoma

(2011) H. Colman et al.   NEURO-ONCOLOGY

Distinct germ line polymorphisms underlie glioma morphologic heterogeneity

(2011) Robert B. Jenkins et al.   Cancer Genetics

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Genetic Risk Profiles Identify Different Molecular Etiologies for Glioma

(2010) M. Simon et al.   CLINICAL CANCER RESEARCH

Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma Survival

(2010) Yanhong Liu et al.   JOURNAL OF CLINICAL ONCOLOGY

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

(2010) C. Houillier et al.   NEUROLOGY

The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas

(2010) Lee A. D. Cooper et al.   PLoS One

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

(2009) Margaret Wrensch et al.   NATURE GENETICS

Genome-wide association study identifies five susceptibility loci for glioma

(2009) Sanjay Shete et al.   NATURE GENETICS

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Common D302H Variant of CASP8 Is Associated with Risk of Glioma

(2008) L. Bethke et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults

(2008) S. Kesari et al.   CLINICAL CANCER RESEARCH

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

(2008) A. Tosoni et al.   JOURNAL OF NEURO-ONCOLOGY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE

Quality of life in low-grade glioma patients receiving temozolomide

(2008) Raymond Liu et al.   NEURO-ONCOLOGY

GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME

(2008) Nader Sanai et al.   NEUROSURGERY

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

(2008) D. W. Parsons et al.   SCIENCE

TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas

(2007) Vítor Lima-Ramos et al.   CANCER GENETICS AND CYTOGENETICS